LYRM2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.75320002959722E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.179920E-04 |
Normal-vs-Stage2 |
1.477460E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.376100E-03 |
Stage1-vs-Stage2 |
5.967400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.599200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.105400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.47439999495813E-08 |
Normal-vs-AfricanAmerican |
2.406800E-01 |
Normal-vs-Asian |
5.712400E-02 |
Caucasian-vs-AfricanAmerican |
2.264000E-02 |
Caucasian-vs-Asian |
3.912400E-01 |
AfricanAmerican-vs-Asian |
3.174000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.37410000003546E-06 |
Normal-vs-Female |
6.31989999999583E-05 |
Male-vs-Female |
7.222600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.844000E-03 |
Normal-vs-Extreme_Weight |
5.177000E-04 |
Normal-vs-Obese |
4.741900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.449400E-01 |
Normal_Weight-vs-Obese |
4.014800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.547600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.004200E-01 |
Normal-vs-Age(41-60Yrs) |
2.016300E-03 |
Normal-vs-Age(61-80Yrs) |
1.96329999999634E-05 |
Normal-vs-Age(81-100Yrs) |
2.6133999997402E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.598600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.533400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.442800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.799200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.334400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.156600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.877800E-01 |
Normal-vs-Grade 3 |
4.378800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.011800E-01 |
Grade 2-vs-Grade 4 |
4.877800E-01 |
Grade 3-vs-Grade 4 |
4.378800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.78919999996408E-06 |
Normal-vs-N1 |
1.483740E-02 |
N0-vs-N1 |
5.822800E-01 |
|
|